Back to Search Start Over

Recent advances in understanding Type 1 Diabetes [version 1; referees: 2 approved]

Authors :
Gustaf Christoffersson
Teresa Rodriguez-Calvo
Matthias von Herrath
Author Affiliations :
<relatesTo>1</relatesTo>Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, California, 92037, USA<br /><relatesTo>2</relatesTo>Novo Nordisk Diabetes Research & Development Center, Seattle, Washington, 98109, USA
Source :
F1000Research. 5:F1000 Faculty Rev-110
Publication Year :
2016
Publisher :
London, UK: F1000 Research Limited, 2016.

Abstract

Type 1 diabetes is a multifactorial disease in which genetic and environmental factors play a key role. The triggering event is still obscure, and so are many of the immune events that follow. In this brief review, we discuss the possible role of potential environmental factors and which triggers are believed to have a role in the disease. In addition, as the disease evolves, beta cells are lost and this occurs in a very heterogeneous fashion. Our knowledge of how beta cell mass declines and our view of the disease’s pathogenesis are also debated. We highlight the major hallmarks of disease, among which are MHC-I (major histocompatibility complex class I) expression and insulitis. The dependence versus independence of antigen for the immune infiltrate is also discussed, as both the influence from bystander T cells and the formation of neo-epitopes through post-translational modifications are thought to influence the course of the disease. As human studies are proliferating, our understanding of the disease’s pathogenesis will increase exponentially. This article aims to shed light on some of the burning questions in type 1 diabetes research.

Details

ISSN :
20461402
Volume :
5
Database :
F1000Research
Journal :
F1000Research
Notes :
Editorial Note on the Review Process F1000 Faculty Reviews are commissioned from members of the prestigious F1000 Faculty and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version). The referees who approved this article are: Li Wen, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut, USA No competing interests were disclosed. Alberto Pugliese, Diabetes Research Institute and Departments of Medicine, Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, USA No competing interests were disclosed., , [version 1; referees: 2 approved]
Publication Type :
Academic Journal
Accession number :
edsfor.10.12688.f1000research.7356.1
Document Type :
review
Full Text :
https://doi.org/10.12688/f1000research.7356.1